The phase II study was designed to evaluate whether inhaled insulin delivered through the Lilly/Alkermes system and injected insulin showed similar effectiveness at controlling blood sugar based on
The data indicates that the combination treatment provides longer event-free survival (EFS) in patients with relapsed or refractory non-Hodgkin’s lymphoma (NHL) when compared to previous results with Rituxan
Clinical research conducted by the company in association with Oregon Health & Science University (OHSU) indicates that FOXP3, known to be involved in maintaining immune tolerance and regulation
The Global Alliance for TB Drug Development, also called the TB Alliance, was granted exclusive worldwide rights to PA-824 and related compounds by Chiron together with a commitment
The research and development company has also decided to initiate an expanded access program for TMC114, its investigational protease inhibitor, in the autumn of 2005 for people with
The vaccine is expected to enter phase II human trials in hematopoietic cell transplant (HCT) donor-recipients in the second half of 2005. The Orphan Drug Act is intended
Indiplon is a unique non-narcotic, non-benzodiazapine agent that acts on a specific site of the GABA-A receptor. Indiplon has been shown to bind selectively to the specific subtype
The US patent office has allowed GenoMed’s claims to use an existing drug for an alternative use. A full patent is anticipated to arrive in the near future,
The Authenticated radio frequency identification (RFID) Platform works by delivering authentication between each end of the supply chain. A Texas Instruments RFID tag is placed on each package
The phase II study recruited patients with mild to moderate psoriasis, a chronic skin disorder which creates an excess of skin cells that pile up on the skin
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.